IRADIMED CORPORATION (IRMD) return on equity (ROE)

Return on equity · fiscal 2025
23.8%

IRADIMED CORPORATION (IRMD) earned a return on equity of 23.8% in fiscal 2025 (the year ended December 31, 2025). That is 1.6 percentage points higher than the 22.2% of fiscal 2024. Figures as of 18 Nov 2026, 12:56 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
23.8%
Change on fiscal 2024
+1.6 pts
Highest on record
35.7%fiscal 2013
Lowest on record
1.5%fiscal 2017
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

IRADIMED CORPORATION return on equity (ROE), in more detail

Across the 13 fiscal years on record (2013–2025), the highest was 35.7% in fiscal 2013 and the lowest 1.5% in fiscal 2017. The fiscal 2025 figure is higher than in 83% of the 12 earlier fiscal years on record, whose median is 17.4%.

History · 13 fiscal years

Return on equity by fiscal year

IRADIMED CORPORATION return on equity (ROE), year by year

IRADIMED CORPORATION (IRMD) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202523.8% 1.6 pts up
202422.2% 1.9 pts down
202324.1% 6.7 pts up
202217.4% 4.5 pts up
202112.9% 10.7 pts up
20202.2% 15.1 pts down
201917.3% 2.3 pts up
201815.0% 13.5 pts up
20171.5% 21.1 pts down
201622.6% 1.0 pts down
201523.6% 13.8 pts up
20149.8% 25.9 pts down
201335.7%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on IRMD

IRADIMED CORPORATION, figure by figure

IRADIMED CORPORATION (IRMD) overview: price, valuation and scorecard

IRADIMED CORPORATION return on equity (ROE): questions and answers

What is IRADIMED CORPORATION's return on equity?

IRADIMED CORPORATION (IRMD) earned a return on equity of 23.8% in fiscal 2025 (the year ended December 31, 2025). That is 1.6 percentage points higher than the 22.2% of fiscal 2024.

Is IRADIMED CORPORATION's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 83% of the 12 earlier fiscal years on record, whose median is 17.4%.

What are the highest and lowest return on equity figures on record for IRADIMED CORPORATION?

Across the 13 fiscal years on record (2013–2025), the highest was 35.7% in fiscal 2013 and the lowest 1.5% in fiscal 2017.

How is IRADIMED CORPORATION's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative. For IRADIMED CORPORATION it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “IRADIMED CORPORATION (IRMD) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/IRMD/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.